Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Submitted by
admin
on April 23, 2014 - 12:02pm
Source:
Fierce Pharma
News Tags:
breast cancer
Roche
NICE
Kadcyla
HER2-positive metastatic breast cancer
Headline:
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Do Not Allow Advertisers to Use My Personal information
